General Information of Drug Transporter (DT)
DT ID DTD0427 Transporter Info
Gene Name SLC5A7
Transporter Name High affinity choline transporter 1
Gene ID
60482
UniProt ID
Q9GZV3
Epigenetic Regulations of This DT (EGR)

Methylation

  Lung squamous cell carcinoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Hypomethylation of SLC5A7 in lung squamous cell carcinoma [ 1 ]

Epigenetic Type

Methylation Experiment Method TCGA database

Related Molecular Changes

Up regulation of SLC5A7 Experiment Method RNAseq

Studied Phenotype

Lung squamous cell carcinoma [ ICD-11: 2C25.2]

Experimental Material

Patient tissue samples

Additional Notes

SLC5A7 was upregulated and hypomethylated in lung squamous cell carcinoma.

  Lung adenocarcinoma

         12 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Hypermethylation of SLC5A7 in lung adenocarcinoma [ 1 ]

Epigenetic Type

Methylation Experiment Method TCGA database

Related Molecular Changes

Down regulation of SLC5A7 Experiment Method RNAseq

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

Additional Notes

SLC5A7 had increased methylation and decreased expression in lung squamous cell carcinoma

  Epigenetic Phenomenon 2

Methylation of SLC5A7 in lung adenocarcinoma [ 10 ]

Location

5'UTR (cg06662812)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.32E+00 Statistic Test p-value: 1.88E-03; Z-score: 2.91E+00

Methylation in Case

2.89E-01 (Median) Methylation in Control 2.19E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A7 in lung adenocarcinoma [ 10 ]

Location

5'UTR (cg07186154)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.84E+00 Statistic Test p-value: 1.98E-03; Z-score: 4.86E+00

Methylation in Case

2.76E-01 (Median) Methylation in Control 1.49E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A7 in lung adenocarcinoma [ 10 ]

Location

5'UTR (cg20547653)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.16E+00 Statistic Test p-value: 6.79E-03; Z-score: 1.96E+00

Methylation in Case

3.22E-01 (Median) Methylation in Control 2.77E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC5A7 in lung adenocarcinoma [ 10 ]

Location

TSS1500 (cg03983336)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.17E+00 Statistic Test p-value: 2.78E-03; Z-score: 1.83E+00

Methylation in Case

7.57E-01 (Median) Methylation in Control 6.45E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC5A7 in lung adenocarcinoma [ 10 ]

Location

TSS1500 (cg17679621)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.21E+00 Statistic Test p-value: 1.76E-02; Z-score: 1.49E+00

Methylation in Case

3.67E-01 (Median) Methylation in Control 3.02E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC5A7 in lung adenocarcinoma [ 10 ]

Location

TSS200 (cg11355135)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.69E+00 Statistic Test p-value: 2.29E-04; Z-score: 6.09E+00

Methylation in Case

4.29E-01 (Median) Methylation in Control 2.54E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC5A7 in lung adenocarcinoma [ 10 ]

Location

TSS200 (cg14613271)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.63E+00 Statistic Test p-value: 2.02E-03; Z-score: 3.73E+00

Methylation in Case

2.21E-01 (Median) Methylation in Control 1.35E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC5A7 in lung adenocarcinoma [ 10 ]

Location

TSS200 (cg26001902)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.73E+00 Statistic Test p-value: 4.00E-03; Z-score: 4.99E+00

Methylation in Case

2.67E-01 (Median) Methylation in Control 1.54E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC5A7 in lung adenocarcinoma [ 10 ]

Location

TSS200 (cg18771173)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.38E+00 Statistic Test p-value: 8.92E-03; Z-score: 1.68E+00

Methylation in Case

1.59E-01 (Median) Methylation in Control 1.15E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC5A7 in lung adenocarcinoma [ 10 ]

Location

TSS200 (cg05311412)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.51E+00 Statistic Test p-value: 2.81E-02; Z-score: 2.60E+00

Methylation in Case

1.71E-01 (Median) Methylation in Control 1.13E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC5A7 in lung adenocarcinoma [ 10 ]

Location

Body (cg05099596)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.07E+00 Statistic Test p-value: 3.75E-02; Z-score: -1.68E+00

Methylation in Case

7.66E-01 (Median) Methylation in Control 8.16E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Atypical teratoid rhabdoid tumor

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A7 in atypical teratoid rhabdoid tumor [ 2 ]

Location

5'UTR (cg06662812)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.43E+00 Statistic Test p-value: 6.68E-08; Z-score: -1.09E+00

Methylation in Case

3.42E-01 (Median) Methylation in Control 4.89E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A7 in atypical teratoid rhabdoid tumor [ 2 ]

Location

5'UTR (cg07186154)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.34E+00 Statistic Test p-value: 8.18E-08; Z-score: 1.45E+00

Methylation in Case

4.69E-01 (Median) Methylation in Control 3.50E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A7 in atypical teratoid rhabdoid tumor [ 2 ]

Location

5'UTR (cg20547653)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.19E+00 Statistic Test p-value: 4.77E-06; Z-score: -1.16E+00

Methylation in Case

6.78E-01 (Median) Methylation in Control 8.03E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A7 in atypical teratoid rhabdoid tumor [ 2 ]

Location

Body (cg05099596)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 1.23E-03; Z-score: -1.96E-01

Methylation in Case

7.51E-01 (Median) Methylation in Control 7.72E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Bladder cancer

           5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A7 in bladder cancer [ 3 ]

Location

5'UTR (cg20547653)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.17E+00 Statistic Test p-value: 1.37E-02; Z-score: -2.66E+00

Methylation in Case

1.64E-01 (Median) Methylation in Control 1.92E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A7 in bladder cancer [ 3 ]

Location

TSS1500 (cg17052964)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.09E+00 Statistic Test p-value: 6.81E-05; Z-score: 4.27E+00

Methylation in Case

7.43E-01 (Median) Methylation in Control 6.84E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A7 in bladder cancer [ 3 ]

Location

TSS1500 (cg03983336)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.15E+00 Statistic Test p-value: 2.01E-03; Z-score: 3.53E+00

Methylation in Case

7.71E-01 (Median) Methylation in Control 6.71E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A7 in bladder cancer [ 3 ]

Location

TSS200 (cg11355135)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.55E+00 Statistic Test p-value: 9.78E-03; Z-score: -3.89E+00

Methylation in Case

1.05E-01 (Median) Methylation in Control 1.63E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC5A7 in bladder cancer [ 3 ]

Location

Body (cg14772660)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.33E+00 Statistic Test p-value: 1.13E-11; Z-score: -1.38E+01

Methylation in Case

3.51E-01 (Median) Methylation in Control 8.15E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Breast cancer

         13 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A7 in breast cancer [ 4 ]

Location

5'UTR (cg06662812)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.42E+00 Statistic Test p-value: 1.73E-11; Z-score: 2.36E+00

Methylation in Case

2.42E-01 (Median) Methylation in Control 1.70E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A7 in breast cancer [ 4 ]

Location

5'UTR (cg20547653)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.40E+00 Statistic Test p-value: 1.63E-09; Z-score: 1.64E+00

Methylation in Case

2.37E-01 (Median) Methylation in Control 1.69E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A7 in breast cancer [ 4 ]

Location

5'UTR (cg07186154)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.07E+00 Statistic Test p-value: 7.77E-08; Z-score: 1.62E+00

Methylation in Case

1.55E-01 (Median) Methylation in Control 7.49E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A7 in breast cancer [ 4 ]

Location

TSS1500 (cg17679621)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.39E+00 Statistic Test p-value: 2.83E-09; Z-score: 2.57E+00

Methylation in Case

3.99E-01 (Median) Methylation in Control 2.87E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC5A7 in breast cancer [ 4 ]

Location

TSS1500 (cg22415472)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.13E+00 Statistic Test p-value: 5.81E-08; Z-score: -2.15E+00

Methylation in Case

6.98E-01 (Median) Methylation in Control 7.90E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC5A7 in breast cancer [ 4 ]

Location

TSS1500 (cg03983336)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.08E+00 Statistic Test p-value: 1.40E-02; Z-score: 8.98E-01

Methylation in Case

7.28E-01 (Median) Methylation in Control 6.76E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC5A7 in breast cancer [ 4 ]

Location

TSS200 (cg11355135)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.79E+00 Statistic Test p-value: 1.91E-15; Z-score: 3.20E+00

Methylation in Case

3.73E-01 (Median) Methylation in Control 2.08E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC5A7 in breast cancer [ 4 ]

Location

TSS200 (cg26001902)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 3.80E+00 Statistic Test p-value: 6.10E-15; Z-score: 3.48E+00

Methylation in Case

2.73E-01 (Median) Methylation in Control 7.18E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC5A7 in breast cancer [ 4 ]

Location

TSS200 (cg18771173)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 4.04E+00 Statistic Test p-value: 2.20E-13; Z-score: 5.13E+00

Methylation in Case

2.00E-01 (Median) Methylation in Control 4.95E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC5A7 in breast cancer [ 4 ]

Location

TSS200 (cg14613271)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.41E+00 Statistic Test p-value: 5.22E-12; Z-score: 2.84E+00

Methylation in Case

1.52E-01 (Median) Methylation in Control 6.29E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC5A7 in breast cancer [ 4 ]

Location

TSS200 (cg05311412)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 3.93E+00 Statistic Test p-value: 8.82E-12; Z-score: 3.09E+00

Methylation in Case

1.69E-01 (Median) Methylation in Control 4.29E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC5A7 in breast cancer [ 4 ]

Location

Body (cg05099596)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.10E+00 Statistic Test p-value: 3.20E-08; Z-score: -2.11E+00

Methylation in Case

6.98E-01 (Median) Methylation in Control 7.65E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 13

Methylation of SLC5A7 in breast cancer [ 4 ]

Location

Body (cg14772660)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 3.47E-03; Z-score: -3.14E-01

Methylation in Case

7.71E-01 (Median) Methylation in Control 7.86E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Renal cell carcinoma

           8 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A7 in clear cell renal cell carcinoma [ 5 ]

Location

5'UTR (cg07186154)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.14E+00 Statistic Test p-value: 2.51E-05; Z-score: 1.24E+00

Methylation in Case

9.25E-02 (Median) Methylation in Control 4.32E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A7 in clear cell renal cell carcinoma [ 5 ]

Location

TSS1500 (cg22415472)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.09E+00 Statistic Test p-value: 1.88E-08; Z-score: -3.91E+00

Methylation in Case

8.85E-01 (Median) Methylation in Control 9.65E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A7 in clear cell renal cell carcinoma [ 5 ]

Location

TSS1500 (cg17679621)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.49E+00 Statistic Test p-value: 1.69E-05; Z-score: 2.44E+00

Methylation in Case

3.78E-01 (Median) Methylation in Control 2.54E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A7 in clear cell renal cell carcinoma [ 5 ]

Location

TSS200 (cg26001902)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.78E+00 Statistic Test p-value: 7.58E-06; Z-score: 2.39E+00

Methylation in Case

9.18E-02 (Median) Methylation in Control 3.30E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC5A7 in clear cell renal cell carcinoma [ 5 ]

Location

TSS200 (cg18771173)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.31E+00 Statistic Test p-value: 3.61E-03; Z-score: 1.45E+00

Methylation in Case

4.25E-02 (Median) Methylation in Control 3.24E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC5A7 in clear cell renal cell carcinoma [ 5 ]

Location

TSS200 (cg05311412)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.42E+00 Statistic Test p-value: 4.11E-03; Z-score: 2.49E+00

Methylation in Case

4.41E-02 (Median) Methylation in Control 3.10E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC5A7 in clear cell renal cell carcinoma [ 5 ]

Location

TSS200 (cg14613271)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.33E+00 Statistic Test p-value: 4.53E-03; Z-score: 1.81E+00

Methylation in Case

5.39E-02 (Median) Methylation in Control 4.06E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC5A7 in clear cell renal cell carcinoma [ 5 ]

Location

Body (cg05099596)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.07E+00 Statistic Test p-value: 3.59E-06; Z-score: -2.08E+00

Methylation in Case

8.47E-01 (Median) Methylation in Control 9.02E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Colon cancer

           8 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A7 in colon adenocarcinoma [ 6 ]

Location

5'UTR (cg26279668)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.98E+00 Statistic Test p-value: 2.28E-07; Z-score: 6.24E+00

Methylation in Case

5.33E-01 (Median) Methylation in Control 2.70E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A7 in colon adenocarcinoma [ 6 ]

Location

5'UTR (cg13563026)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.30E+00 Statistic Test p-value: 1.08E-05; Z-score: -2.24E+00

Methylation in Case

2.67E-01 (Median) Methylation in Control 3.46E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A7 in colon adenocarcinoma [ 6 ]

Location

TSS1500 (cg14918082)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.16E+00 Statistic Test p-value: 5.85E-06; Z-score: 1.24E+00

Methylation in Case

7.43E-01 (Median) Methylation in Control 6.42E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A7 in colon adenocarcinoma [ 6 ]

Location

TSS1500 (cg26062856)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.17E+00 Statistic Test p-value: 5.90E-04; Z-score: -4.00E+00

Methylation in Case

5.57E-01 (Median) Methylation in Control 6.51E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC5A7 in colon adenocarcinoma [ 6 ]

Location

TSS1500 (cg19645639)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.52E+00 Statistic Test p-value: 7.10E-04; Z-score: -1.56E+00

Methylation in Case

2.48E-01 (Median) Methylation in Control 3.76E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC5A7 in colon adenocarcinoma [ 6 ]

Location

TSS200 (cg09530407)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.67E+00 Statistic Test p-value: 6.65E-04; Z-score: 2.97E+00

Methylation in Case

2.67E-01 (Median) Methylation in Control 1.60E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC5A7 in colon adenocarcinoma [ 6 ]

Location

Body (cg00465739)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.50E+00 Statistic Test p-value: 3.32E-06; Z-score: -2.34E+00

Methylation in Case

3.54E-01 (Median) Methylation in Control 5.30E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC5A7 in colon adenocarcinoma [ 6 ]

Location

Body (cg14857792)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.26E+00 Statistic Test p-value: 1.33E-05; Z-score: -3.01E+00

Methylation in Case

5.41E-01 (Median) Methylation in Control 6.79E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Colorectal cancer

         13 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A7 in colorectal cancer [ 7 ]

Location

5'UTR (cg07186154)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 3.94E+00 Statistic Test p-value: 1.96E-21; Z-score: 7.43E+00

Methylation in Case

4.31E-01 (Median) Methylation in Control 1.09E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A7 in colorectal cancer [ 7 ]

Location

5'UTR (cg06662812)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.31E+00 Statistic Test p-value: 2.04E-06; Z-score: 1.56E+00

Methylation in Case

6.06E-01 (Median) Methylation in Control 4.63E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A7 in colorectal cancer [ 7 ]

Location

5'UTR (cg20547653)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.30E+00 Statistic Test p-value: 1.09E-05; Z-score: 1.07E+00

Methylation in Case

3.21E-01 (Median) Methylation in Control 2.46E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A7 in colorectal cancer [ 7 ]

Location

TSS1500 (cg22415472)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.19E+00 Statistic Test p-value: 1.88E-12; Z-score: -4.65E+00

Methylation in Case

7.14E-01 (Median) Methylation in Control 8.47E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC5A7 in colorectal cancer [ 7 ]

Location

TSS1500 (cg17679621)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.21E+00 Statistic Test p-value: 1.80E-05; Z-score: 1.47E+00

Methylation in Case

5.55E-01 (Median) Methylation in Control 4.59E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC5A7 in colorectal cancer [ 7 ]

Location

TSS200 (cg05311412)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 4.43E+00 Statistic Test p-value: 7.78E-17; Z-score: 6.69E+00

Methylation in Case

4.05E-01 (Median) Methylation in Control 9.14E-02 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC5A7 in colorectal cancer [ 7 ]

Location

TSS200 (cg14613271)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 3.02E+00 Statistic Test p-value: 1.23E-14; Z-score: 4.45E+00

Methylation in Case

3.65E-01 (Median) Methylation in Control 1.21E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC5A7 in colorectal cancer [ 7 ]

Location

TSS200 (cg18771173)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.86E+00 Statistic Test p-value: 1.20E-13; Z-score: 3.78E+00

Methylation in Case

3.93E-01 (Median) Methylation in Control 1.37E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC5A7 in colorectal cancer [ 7 ]

Location

TSS200 (cg11355135)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.51E+00 Statistic Test p-value: 4.63E-13; Z-score: 3.14E+00

Methylation in Case

6.93E-01 (Median) Methylation in Control 4.59E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC5A7 in colorectal cancer [ 7 ]

Location

TSS200 (cg26001902)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.45E+00 Statistic Test p-value: 1.21E-12; Z-score: 3.29E+00

Methylation in Case

5.49E-01 (Median) Methylation in Control 2.24E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC5A7 in colorectal cancer [ 7 ]

Location

Body (cg05099596)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.11E+00 Statistic Test p-value: 5.76E-11; Z-score: -4.54E+00

Methylation in Case

7.91E-01 (Median) Methylation in Control 8.76E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC5A7 in colorectal cancer [ 7 ]

Location

Body (cg14772660)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.07E+00 Statistic Test p-value: 4.45E-08; Z-score: -4.05E+00

Methylation in Case

8.53E-01 (Median) Methylation in Control 9.12E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Hepatocellular carcinoma

         16 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A7 in hepatocellular carcinoma [ 8 ]

Location

5'UTR (cg20547653)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.00E+00 Statistic Test p-value: 2.53E-02; Z-score: 1.16E-02

Methylation in Case

1.95E-01 (Median) Methylation in Control 1.94E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A7 in hepatocellular carcinoma [ 8 ]

Location

5'UTR (cg06662812)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.03E+00 Statistic Test p-value: 3.63E-02; Z-score: 1.60E-01

Methylation in Case

2.05E-01 (Median) Methylation in Control 1.99E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A7 in hepatocellular carcinoma [ 8 ]

Location

TSS1500 (cg19645639)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.43E+00 Statistic Test p-value: 2.01E-19; Z-score: -2.46E+00

Methylation in Case

1.64E-01 (Median) Methylation in Control 4.00E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A7 in hepatocellular carcinoma [ 8 ]

Location

TSS1500 (cg09454187)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.55E+00 Statistic Test p-value: 1.26E-15; Z-score: -5.20E+00

Methylation in Case

4.75E-01 (Median) Methylation in Control 7.36E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC5A7 in hepatocellular carcinoma [ 8 ]

Location

TSS1500 (cg01109535)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.35E+00 Statistic Test p-value: 2.14E-13; Z-score: -2.02E+00

Methylation in Case

3.35E-01 (Median) Methylation in Control 4.51E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC5A7 in hepatocellular carcinoma [ 8 ]

Location

TSS1500 (cg00826767)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.36E+00 Statistic Test p-value: 1.03E-10; Z-score: -1.76E+00

Methylation in Case

4.85E-01 (Median) Methylation in Control 6.59E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC5A7 in hepatocellular carcinoma [ 8 ]

Location

TSS1500 (cg17052964)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.24E+00 Statistic Test p-value: 3.37E-08; Z-score: -2.02E+00

Methylation in Case

5.42E-01 (Median) Methylation in Control 6.72E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC5A7 in hepatocellular carcinoma [ 8 ]

Location

TSS1500 (cg22415472)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.16E+00 Statistic Test p-value: 1.14E-06; Z-score: -1.29E+00

Methylation in Case

5.57E-01 (Median) Methylation in Control 6.46E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC5A7 in hepatocellular carcinoma [ 8 ]

Location

TSS1500 (cg03983336)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.19E+00 Statistic Test p-value: 3.58E-05; Z-score: -1.16E+00

Methylation in Case

4.91E-01 (Median) Methylation in Control 5.87E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC5A7 in hepatocellular carcinoma [ 8 ]

Location

TSS200 (cg11264635)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.57E+00 Statistic Test p-value: 7.55E-21; Z-score: -4.89E+00

Methylation in Case

4.00E-01 (Median) Methylation in Control 6.27E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC5A7 in hepatocellular carcinoma [ 8 ]

Location

TSS200 (cg26001902)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.28E+00 Statistic Test p-value: 6.37E-04; Z-score: 4.39E-01

Methylation in Case

1.46E-01 (Median) Methylation in Control 1.14E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC5A7 in hepatocellular carcinoma [ 8 ]

Location

Body (cg15027358)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.87E+00 Statistic Test p-value: 2.27E-21; Z-score: -1.32E+01

Methylation in Case

4.44E-01 (Median) Methylation in Control 8.30E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 13

Methylation of SLC5A7 in hepatocellular carcinoma [ 8 ]

Location

Body (cg09358975)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.79E+00 Statistic Test p-value: 8.64E-21; Z-score: -4.39E+00

Methylation in Case

4.13E-01 (Median) Methylation in Control 7.41E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 14

Methylation of SLC5A7 in hepatocellular carcinoma [ 8 ]

Location

Body (cg12933431)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.56E+00 Statistic Test p-value: 1.69E-16; Z-score: -2.32E+00

Methylation in Case

4.23E-01 (Median) Methylation in Control 6.61E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 15

Methylation of SLC5A7 in hepatocellular carcinoma [ 8 ]

Location

Body (cg08739738)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.55E+00 Statistic Test p-value: 9.11E-12; Z-score: -2.35E+00

Methylation in Case

4.10E-01 (Median) Methylation in Control 6.33E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 16

Methylation of SLC5A7 in hepatocellular carcinoma [ 8 ]

Location

3'UTR (cg16920502)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.76E+00 Statistic Test p-value: 2.66E-18; Z-score: -5.99E+00

Methylation in Case

4.13E-01 (Median) Methylation in Control 7.30E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  HIV infection

         11 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A7 in HIV infection [ 9 ]

Location

5'UTR (cg07186154)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.39E+00 Statistic Test p-value: 6.93E-07; Z-score: 2.82E+00

Methylation in Case

1.80E-01 (Median) Methylation in Control 7.52E-02 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A7 in HIV infection [ 9 ]

Location

5'UTR (cg06662812)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.40E+00 Statistic Test p-value: 4.10E-06; Z-score: 2.19E+00

Methylation in Case

2.20E-01 (Median) Methylation in Control 1.57E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A7 in HIV infection [ 9 ]

Location

5'UTR (cg20547653)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.41E+00 Statistic Test p-value: 1.46E-05; Z-score: 2.72E+00

Methylation in Case

2.21E-01 (Median) Methylation in Control 1.57E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A7 in HIV infection [ 9 ]

Location

TSS1500 (cg22415472)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 2.86E-02; Z-score: -6.46E-01

Methylation in Case

8.51E-01 (Median) Methylation in Control 8.68E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC5A7 in HIV infection [ 9 ]

Location

TSS1500 (cg17679621)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.08E+00 Statistic Test p-value: 2.99E-02; Z-score: 5.48E-01

Methylation in Case

4.21E-01 (Median) Methylation in Control 3.89E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC5A7 in HIV infection [ 9 ]

Location

TSS1500 (cg17052964)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.02E+00 Statistic Test p-value: 3.60E-02; Z-score: 4.07E-01

Methylation in Case

7.08E-01 (Median) Methylation in Control 6.91E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC5A7 in HIV infection [ 9 ]

Location

TSS200 (cg26001902)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.40E+00 Statistic Test p-value: 1.37E-05; Z-score: 2.79E+00

Methylation in Case

2.51E-01 (Median) Methylation in Control 1.05E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC5A7 in HIV infection [ 9 ]

Location

TSS200 (cg18771173)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.94E+00 Statistic Test p-value: 1.37E-05; Z-score: 2.15E+00

Methylation in Case

1.45E-01 (Median) Methylation in Control 7.49E-02 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC5A7 in HIV infection [ 9 ]

Location

TSS200 (cg11355135)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.32E+00 Statistic Test p-value: 1.93E-05; Z-score: 1.47E+00

Methylation in Case

3.67E-01 (Median) Methylation in Control 2.78E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC5A7 in HIV infection [ 9 ]

Location

TSS200 (cg05311412)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.43E+00 Statistic Test p-value: 2.03E-04; Z-score: 1.29E+00

Methylation in Case

1.23E-01 (Median) Methylation in Control 8.62E-02 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC5A7 in HIV infection [ 9 ]

Location

TSS200 (cg14613271)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.25E+00 Statistic Test p-value: 4.47E-04; Z-score: 9.21E-01

Methylation in Case

1.79E-01 (Median) Methylation in Control 1.43E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Pancretic ductal adenocarcinoma

           5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A7 in pancretic ductal adenocarcinoma [ 11 ]

Location

5'UTR (cg06696917)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 3.30E-02; Z-score: -2.67E-01

Methylation in Case

7.34E-02 (Median) Methylation in Control 7.73E-02 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A7 in pancretic ductal adenocarcinoma [ 11 ]

Location

TSS200 (cg10569606)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 4.90E+00 Statistic Test p-value: 3.33E-51; Z-score: 9.62E+00

Methylation in Case

3.26E-01 (Median) Methylation in Control 6.65E-02 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A7 in pancretic ductal adenocarcinoma [ 11 ]

Location

Body (cg03049846)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.28E+00 Statistic Test p-value: 7.27E-33; Z-score: -4.29E+00

Methylation in Case

5.25E-01 (Median) Methylation in Control 6.73E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A7 in pancretic ductal adenocarcinoma [ 11 ]

Location

Body (cg01792749)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.22E+00 Statistic Test p-value: 5.10E-04; Z-score: -1.03E+00

Methylation in Case

5.63E-01 (Median) Methylation in Control 6.87E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC5A7 in pancretic ductal adenocarcinoma [ 11 ]

Location

Body (cg10333311)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.10E+00 Statistic Test p-value: 3.46E-03; Z-score: 8.65E-01

Methylation in Case

7.06E-01 (Median) Methylation in Control 6.44E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Prostate cancer

         10 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A7 in prostate cancer [ 12 ]

Location

5'UTR (cg13598790)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.44E+00 Statistic Test p-value: 8.23E-03; Z-score: 2.34E+00

Methylation in Case

4.03E-02 (Median) Methylation in Control 2.81E-02 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A7 in prostate cancer [ 12 ]

Location

5'UTR (cg14411266)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 3.57E+00 Statistic Test p-value: 1.74E-02; Z-score: 3.34E+00

Methylation in Case

3.26E-01 (Median) Methylation in Control 9.11E-02 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A7 in prostate cancer [ 12 ]

Location

TSS1500 (cg16729160)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 4.01E+00 Statistic Test p-value: 3.13E-02; Z-score: 4.40E+01

Methylation in Case

2.61E-01 (Median) Methylation in Control 6.51E-02 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A7 in prostate cancer [ 12 ]

Location

TSS200 (cg25212131)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.13E+00 Statistic Test p-value: 3.46E-02; Z-score: 2.06E+00

Methylation in Case

6.94E-01 (Median) Methylation in Control 6.16E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC5A7 in prostate cancer [ 12 ]

Location

1stExon (cg04592706)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.02E+00 Statistic Test p-value: 1.18E-02; Z-score: 2.14E+00

Methylation in Case

9.57E-01 (Median) Methylation in Control 9.35E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC5A7 in prostate cancer [ 12 ]

Location

Body (cg20741386)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.08E+00 Statistic Test p-value: 8.85E-03; Z-score: 4.12E+00

Methylation in Case

9.12E-01 (Median) Methylation in Control 8.48E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC5A7 in prostate cancer [ 12 ]

Location

Body (cg08065122)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.20E+00 Statistic Test p-value: 1.65E-02; Z-score: 2.01E+00

Methylation in Case

8.38E-01 (Median) Methylation in Control 6.97E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC5A7 in prostate cancer [ 12 ]

Location

Body (cg09767076)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.24E+00 Statistic Test p-value: 1.88E-02; Z-score: 1.86E+00

Methylation in Case

7.54E-01 (Median) Methylation in Control 6.10E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC5A7 in prostate cancer [ 12 ]

Location

Body (cg13917287)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.03E+00 Statistic Test p-value: 4.71E-02; Z-score: 1.30E+00

Methylation in Case

9.42E-01 (Median) Methylation in Control 9.16E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Significant hypermethylation of SLC5A7 in prostate cancer than that in healthy individual

Studied Phenotype

Prostate cancer [ICD-11:2C82]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 1.49E-23; Fold-change: 0.355725753; Z-score: 12.37408655
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Papillary thyroid cancer

           6 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A7 in papillary thyroid cancer [ 13 ]

Location

TSS1500 (cg17679621)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.21E+00 Statistic Test p-value: 4.81E-05; Z-score: 9.10E-01

Methylation in Case

1.96E-01 (Median) Methylation in Control 1.61E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A7 in papillary thyroid cancer [ 13 ]

Location

TSS1500 (cg03983336)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.11E+00 Statistic Test p-value: 5.08E-05; Z-score: 1.38E+00

Methylation in Case

7.54E-01 (Median) Methylation in Control 6.78E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A7 in papillary thyroid cancer [ 13 ]

Location

TSS1500 (cg22415472)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 1.18E-04; Z-score: -7.16E-01

Methylation in Case

9.25E-01 (Median) Methylation in Control 9.36E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A7 in papillary thyroid cancer [ 13 ]

Location

TSS200 (cg26001902)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.10E+00 Statistic Test p-value: 3.32E-02; Z-score: 3.31E-01

Methylation in Case

9.45E-02 (Median) Methylation in Control 8.56E-02 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC5A7 in papillary thyroid cancer [ 13 ]

Location

Body (cg05099596)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 3.39E-06; Z-score: -9.42E-01

Methylation in Case

8.94E-01 (Median) Methylation in Control 9.12E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC5A7 in papillary thyroid cancer [ 13 ]

Location

Body (cg14772660)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 3.58E-03; Z-score: -6.31E-01

Methylation in Case

8.94E-01 (Median) Methylation in Control 9.08E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Systemic lupus erythematosus

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A7 in systemic lupus erythematosus [ 14 ]

Location

TSS1500 (cg22415472)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 7.45E-03; Z-score: -1.64E-01

Methylation in Case

8.61E-01 (Median) Methylation in Control 8.68E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A7 in systemic lupus erythematosus [ 14 ]

Location

Body (cg05099596)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 8.89E-03; Z-score: -2.12E-01

Methylation in Case

8.29E-01 (Median) Methylation in Control 8.39E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Panic disorder

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A7 in panic disorder [ 15 ]

Location

TSS200 (cg05311412)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -9.86E-01 Statistic Test p-value: 4.15E-02; Z-score: -1.04E-01

Methylation in Case

-3.45E+00 (Median) Methylation in Control -3.40E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A7 in panic disorder [ 15 ]

Location

Body (cg14772660)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.33E+00 Statistic Test p-value: 2.60E-03; Z-score: -4.20E-01

Methylation in Case

5.33E-01 (Median) Methylation in Control 7.10E-01 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Acute myeloid leukemia

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypermethylation of SLC5A7 in acute myeloid leukemia than that in healthy individual

Studied Phenotype

Acute myeloid leukemia [ICD-11:2A60]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 1.16E-10; Fold-change: 0.268524828; Z-score: 1.782379141
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Arterial aneurysm

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypermethylation of SLC5A7 in arterial aneurysm than that in healthy individual

Studied Phenotype

Arterial aneurysm [ICD-11:BD51]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 0.041071028; Fold-change: 0.200615629; Z-score: 1.201622885
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals

  Medulloblastoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypermethylation of SLC5A7 in medulloblastoma than that in healthy individual

Studied Phenotype

Medulloblastoma [ICD-11:2A00.10]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 3.45E-84; Fold-change: 0.284692785; Z-score: 3.43781753
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Glioblastoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypermethylation of SLC5A7 in glioblastoma than that in healthy individual

Studied Phenotype

Glioblastoma [ICD-11:2A00.00]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 5.09E-07; Fold-change: 0.488277974; Z-score: 1.632505164
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Lymphoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypermethylation of SLC5A7 in lymphoma than that in healthy individual

Studied Phenotype

Lymphoma [ICD-11:2B30]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 1.55E-29; Fold-change: 0.646338693; Z-score: 2.989648066
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Malignant astrocytoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypermethylation of SLC5A7 in malignant astrocytoma than that in healthy individual

Studied Phenotype

Malignant astrocytoma [ICD-11:2A00.12]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 2.09E-45; Fold-change: 0.419423536; Z-score: 2.431163165
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Melanoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypermethylation of SLC5A7 in melanoma than that in healthy individual

Studied Phenotype

Melanoma [ICD-11:2C30]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 0.000337613; Fold-change: 0.415145763; Z-score: 1.789280778
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Oligodendroglial tumour

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypermethylation of SLC5A7 in oligodendroglial tumour than that in healthy individual

Studied Phenotype

Oligodendroglial tumour [ICD-11:2A00.Y1]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 5.85E-15; Fold-change: 0.467967268; Z-score: 20.16011341
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Oligodendroglioma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypermethylation of SLC5A7 in oligodendroglioma than that in healthy individual

Studied Phenotype

Oligodendroglioma [ICD-11:2A00.0Y]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 3.96E-25; Fold-change: 0.537552899; Z-score: 2.486457956
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Prostate cancer metastasis

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypermethylation of SLC5A7 in prostate cancer metastasis than that in healthy individual

Studied Phenotype

Prostate cancer metastasis [ICD-11:2.00E+06]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 1.60E-08; Fold-change: 0.504448802; Z-score: 19.15159428
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Gastric cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypermethylation of SLC5A7 in gastric cancer than that in adjacent tissue

Studied Phenotype

Gastric cancer [ICD-11:2B72]

The Methylation Level of Disease Section Compare with the Adjacent Tissue

p-value: 5.43E-30; Fold-change: 0.356816744; Z-score: 39.55765806
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals

microRNA

  Unclear Phenotype

         14 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

miR-192 directly targets SLC5A7 [ 16 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-192 miRNA Mature ID miR-192-3p

miRNA Sequence

CUGCCAAUUCCAUAGGUCACAG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 2

miR-323b directly targets SLC5A7 [ 16 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-323b miRNA Mature ID miR-323b-3p

miRNA Sequence

CCCAAUACACGGUCGACCUCUU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 3

miR-329 directly targets SLC5A7 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-329 miRNA Mature ID miR-329-3p

miRNA Sequence

AACACACCUGGUUAACCUCUUU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 4

miR-362 directly targets SLC5A7 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-362 miRNA Mature ID miR-362-3p

miRNA Sequence

AACACACCUAUUCAAGGAUUCA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 5

miR-3659 directly targets SLC5A7 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-3659 miRNA Mature ID miR-3659

miRNA Sequence

UGAGUGUUGUCUACGAGGGCA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 6

miR-3941 directly targets SLC5A7 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-3941 miRNA Mature ID miR-3941

miRNA Sequence

UUACACACAACUGAGGAUCAUA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 7

miR-4658 directly targets SLC5A7 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-4658 miRNA Mature ID miR-4658

miRNA Sequence

GUGAGUGUGGAUCCUGGAGGAAU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 8

miR-4789 directly targets SLC5A7 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-4789 miRNA Mature ID miR-4789-3p

miRNA Sequence

CACACAUAGCAGGUGUAUAUA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 9

miR-5589 directly targets SLC5A7 [ 16 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-5589 miRNA Mature ID miR-5589-3p

miRNA Sequence

UGCACAUGGCAACCUAGCUCCCA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 10

miR-5692a directly targets SLC5A7 [ 16 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-5692a miRNA Mature ID miR-5692a

miRNA Sequence

CAAAUAAUACCACAGUGGGUGU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 11

miR-574 directly targets SLC5A7 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-574 miRNA Mature ID miR-574-5p

miRNA Sequence

UGAGUGUGUGUGUGUGAGUGUGU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 12

miR-603 directly targets SLC5A7 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-603 miRNA Mature ID miR-603

miRNA Sequence

CACACACUGCAAUUACUUUUGC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 13

miR-6790 directly targets SLC5A7 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-6790 miRNA Mature ID miR-6790-5p

miRNA Sequence

GUGAGUGUGGAUUUGGCGGGGUU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 14

miR-8485 directly targets SLC5A7 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-8485 miRNA Mature ID miR-8485

miRNA Sequence

CACACACACACACACACGUAU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human
References
1 Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma. J Cell Physiol. 2019 Apr;234(4):4454-4459.
2 Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer Cell. 2016 Mar 14;29(3):379-393.
3 DNA Methylation Dynamics in Urological Tumors.
4 Genome-wide Scan for Methylation Profiles in Breast Cancer
5 A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat Commun. 2015 Oct 30;6:8699.
6 Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics. 2013 Sep;8(9):921-34.
7 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
8 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
9 HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015 Nov 15;212(10):1563-73.
10 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
11 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
12 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
13 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
14 Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet. 2013;9(8):e1003678.
15 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.
16 Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe. 2011 Nov 17;10(5):515-26.
17 Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. Genes Dev. 2013 Jul 15;27(14):1624-32.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.